Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis. Malfitano A M, Laezza C, D'Alessandro A, Procaccini C, Saccomanni G, Tuccinardi T, Manera C, Macchia M, Matarese G, Gazzerro P, et al. PLoS One. 2013; 8(5):e62511. Epub 2013 May 01. PMID: 23658734. Abstract CommentRecommendBookmarkWatch